This webinar is the first of Micropoint's educational series. Topics will cover a spectrum of subjects to provide insight in the rapidly evolving healthcare in all parts of the globe.
In this webinar, renowned cardiologist Dr. Alan Maisel discusses the evolution of how biomarkers continue to play a role in the management of heart failure patients. Dr. Maisel highlights the new drug Entresto (sacubatril/valsartan) and the challenges that high sensitivity troponins bring to patient assessment. Case studies are presented to provide a better understanding and practical use of traditional biomarkers like the natriuretic peptides, but also with novel cardiac biomarkers like ST2.15